Unaudited Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net (loss) income	$ (20,388)	$ 739
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,715	2,424
Stock-based compensation expense	784	1,279
Inventory impairments and option contract abandonments	221	3,535
Deferred and other income tax benefit	(102)	(36,065)
Provision for doubtful accounts	(51)	3
Equity in (income) loss of unconsolidated entities	(36)	106
Cash distributions of income from unconsolidated entities	200	0
Changes in operating assets and liabilities:
Decrease in accounts receivable	1,166	333
Decrease in income tax receivable	3,859	1,742
(Increase) decrease in inventory	(38,703)	12,097
Decrease in other assets	1,093	1,485
Decrease in trade accounts payable	(13,206)	(26,300)
Decrease in other liabilities	(24,982)	(32,448)
Other changes	(23)	(17)
Net cash used in operating activities	(87,453)	(71,087)
Cash flows from investing activities:
Capital expenditures	(1,772)	(8,636)
Investments in unconsolidated entities	(115)	(477)
Increases in restricted cash	(278)	(672)
Decreases in restricted cash	2,083	489
Net cash provided by (used in) investing activities	(82)	(9,296)
Cash flows from financing activities:
Repayment of debt	(1,902)	(1,522)
Debt issuance costs	(1,136)	(97)
Settlement of unconsolidated entity debt obligation	(500)	(15,862)
Payments for other financing activities	(26)	(15)
Net cash (used in) provided by financing activities	(3,564)	(17,496)
(Decrease) increase in cash and cash equivalents	(91,099)	(97,879)
Cash and cash equivalents at beginning of period	487,795	370,403
Cash and cash equivalents at end of period	$ 396,696	$ 272,524